Reports - Precision medicine software Market
HealthcarePrecision medicine software Market
Precision medicine software Market: Solutions, Growth & Trends | 2025-2035 by Delivery Mode (On-premise Delivery Mode, Cloud-based Delivery Mode) by End User (Healthcare Providers, Research Centers and Academic Institutes, Pharmaceutical and Biotechnology Companies, Other End Users (non-profit organizations and diagnostic companies)) by Application (Oncology, Pharmacogenomics, Rare Diseases, Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Precision medicine software Market - Segment Analysis
1. Overview
2. Global Precision medicine software Market, 2021 - 2035 (USD Million)
3. Global Precision medicine software Market - by Delivery Mode
3.1. By On-premise Delivery Mode
3.2. By Cloud-based Delivery Mode
4. Global Precision medicine software Market - by End User
4.1. By Healthcare Providers
4.2. By Research Centers and Academic Institutes
4.3. By Pharmaceutical and Biotechnology Companies
4.4. By Other End Users (non-profit organizations and diagnostic companies)
5. Global Precision medicine software Market - by Application
5.1. By Oncology
5.2. By Pharmacogenomics
5.3. By Rare Diseases
5.4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
6. Global Precision medicine software Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Precision medicine software Market - Segment Analysis
1. Overview
2. North America Precision medicine software Market, 2021 - 2035 (USD Million)
3. North America Precision medicine software Market - by Delivery Mode
3.1. By On-premise Delivery Mode
3.2. By Cloud-based Delivery Mode
4. North America Precision medicine software Market - by End User
4.1. By Healthcare Providers
4.2. By Research Centers and Academic Institutes
4.3. By Pharmaceutical and Biotechnology Companies
4.4. By Other End Users (non-profit organizations and diagnostic companies)
5. North America Precision medicine software Market - by Application
5.1. By Oncology
5.2. By Pharmacogenomics
5.3. By Rare Diseases
5.4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
Chapter 5 Europe Precision medicine software Market - Segment Analysis
1. Overview
2. Europe Precision medicine software Market, 2021 - 2035 (USD Million)
3. Europe Precision medicine software Market - by Delivery Mode
3.1. By On-premise Delivery Mode
3.2. By Cloud-based Delivery Mode
4. Europe Precision medicine software Market - by End User
4.1. By Healthcare Providers
4.2. By Research Centers and Academic Institutes
4.3. By Pharmaceutical and Biotechnology Companies
4.4. By Other End Users (non-profit organizations and diagnostic companies)
5. Europe Precision medicine software Market - by Application
5.1. By Oncology
5.2. By Pharmacogenomics
5.3. By Rare Diseases
5.4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
Chapter 6 Asia Pacific Precision medicine software Market - Segment Analysis
1. Overview
2. Asia Pacific Precision medicine software Market, 2021 - 2035 (USD Million)
3. Asia Pacific Precision medicine software Market - by Delivery Mode
3.1. By On-premise Delivery Mode
3.2. By Cloud-based Delivery Mode
4. Asia Pacific Precision medicine software Market - by End User
4.1. By Healthcare Providers
4.2. By Research Centers and Academic Institutes
4.3. By Pharmaceutical and Biotechnology Companies
4.4. By Other End Users (non-profit organizations and diagnostic companies)
5. Asia Pacific Precision medicine software Market - by Application
5.1. By Oncology
5.2. By Pharmacogenomics
5.3. By Rare Diseases
5.4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
Chapter 7 Latin America Precision medicine software Market - Segment Analysis
1. Overview
2. Latin America Precision medicine software Market, 2021 - 2035 (USD Million)
3. Latin America Precision medicine software Market - by Delivery Mode
3.1. By On-premise Delivery Mode
3.2. By Cloud-based Delivery Mode
4. Latin America Precision medicine software Market - by End User
4.1. By Healthcare Providers
4.2. By Research Centers and Academic Institutes
4.3. By Pharmaceutical and Biotechnology Companies
4.4. By Other End Users (non-profit organizations and diagnostic companies)
5. Latin America Precision medicine software Market - by Application
5.1. By Oncology
5.2. By Pharmacogenomics
5.3. By Rare Diseases
5.4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
Chapter 8 Middle East & Africa Precision medicine software Market - Segment Analysis
1. Overview
2. Middle East & Africa Precision medicine software Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Precision medicine software Market - by Delivery Mode
3.1. By On-premise Delivery Mode
3.2. By Cloud-based Delivery Mode
4. Middle East & Africa Precision medicine software Market - by End User
4.1. By Healthcare Providers
4.2. By Research Centers and Academic Institutes
4.3. By Pharmaceutical and Biotechnology Companies
4.4. By Other End Users (non-profit organizations and diagnostic companies)
5. Middle East & Africa Precision medicine software Market - by Application
5.1. By Oncology
5.2. By Pharmacogenomics
5.3. By Rare Diseases
5.4. By Other Applications (neurodegenerative diseases, genetic testing, and carrier screening testing)
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Syapse Inc.
2. 2bprecise
3. LLC
4. Fabric Genomics Inc.
5. Foundation Medicine Inc.
6. Sophia Genetics Sa
7. Pieriandx Inc.
8. N-Of-One Inc. (A Subsidiary of Qiagen N.V.)
9. Human Longevity Inc.
10. Translational Software Inc.
11. Sunquest Information Systems Inc.
12. Gene42 Inc.
13. Lifeomic Health
14. LLC
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By